Scientists continue studying how hemp-derived cannabinoids may support the body’s response to neuroinflammation and neurodegenerative conditions. In the review “Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration,” researchers examined how cannabinoids such as CBD, CBG, and CBC interact with microglia — the immune cells of the central nervous […]
Tag: Parkinson’s
PPAR Activation May Help Protect Brain Cells and Slow Neurodegeneration in Parkinson’s Disease (Pub. Feb 2023)
Parkinson’s disease is a progressive neurological disorder characterized by the loss of dopamine-producing neurons and the buildup of a protein called alpha-synuclein in the brain. In this 2023 scientific review, researchers examined the role of peroxisome proliferator-activated receptors (PPARs)—particularly PPARγ—and their potential neuroprotective effects in Parkinson’s disease. The review highlights growing evidence that activating PPAR […]
Anti-Inflammatory Effects of Cannabinoids in Neurodegenerative and Central Nervous System Disorders (pub. July 2025)
Many neurodegenerative diseases—including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Huntington’s disease—are strongly linked to chronic inflammation within the central nervous system (CNS). This review examines how cannabinoids interact with both the nervous and immune systems and explores their potential role in reducing inflammation that contributes to nerve cell damage. Researchers highlight that […]